Enter your login information. Access is by subscription only. For more details, please contact us.

Username:

Password:

2007-03-07 FDA Approves Tekturna for High Blood Pressure On March 6, 2007, the U.S. Food and Drug Administration (FDA) announced the approval of Novartis' Tecturna (aliskiren... more
2007-02-12 Bayer and Onyx End Trial Due to Positive Results On February 12, 2007, Onyx Pharmaceuticals and Bayer Pharmaceuticals Corporation announced that the 602 patient, rand... more
 
Our emerging health technologies database, TechNotes, and up-to-the-moment reports give you the vital information you need to make timely, informed and efficient decisions concerning health technologies.
Learn more

Emerging health technologies present health system executives with the most complex of decisions. As new drugs, devices and diagnostic tests leave the developmental stage and enter commercialization, they can have dramatic impact on the systems, practitioners and patients for whom they are designed. Our ground breaking approach to emerging health technology surveillance puts you and your organization ahead of the curve. Learn more
As an executive, I appreciate the concise, timely information provided in BioHorizon’s weekly summaries. They have become invaluable tools for our decision-making processes.
Mr. Grant McNeill
www.biohorizon.com
As an executive in the demanding world of health services delivery, staying informed about emerging health technologies isn't a luxury - it's a necessity.

We provide current, concise, ongoing reporting and analysis so you can make better decisions.
 
Copyright © 2005 BioHorizon, Inc. All Rights Reserved :: Privacy Policy :: Terms Of Use